Skip to main content
ADAG logo

Adagene Inc.

ADAGNASDAQHealthcareBiotechnology

$2.49Today:- (-)1Y +36.31%

As of Oct 26, 2026 close

Market cap
$140.98M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.30$4.85
Volume (live)
-
Avg. volume (3M)
342.16K

Adagene (ADAG) Income Statement

Adagene reported revenue of $7.67M in fiscal 2025 (fiscal year ended Mar 31, 2026), up 7332.8% from $103.20K a year earlier. Adagene posted a net loss of $17.61M, compared with a net loss of $33.42M a year earlier. Gross margin was 100.0% and operating margin -279.5%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $1.62M.

Adagene Income Statement Analysis

Values in millions USD

Scroll to see more
Adagene Inc. income statement - Annual data in millions USD
BreakdownFY 2025FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021FY 2020FY 2020FY 2019FY 2018
Period endingMar 2026Dec 2025Dec 2024Dec 2023Dec 2022Mar 2022Dec 2021Mar 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue7.677.670.1018.119.2910.1810.180.480.700.481.51
Cost of Revenue0.00-0.930.000.000.00-0.00-0.000.00
Gross Profit7.677.670.1018.119.2910.1810.180.480.700.481.51
Operating Expenses
Research & Development22.0321.9828.7636.6481.3068.1068.1016.2133.5416.2116.08
Selling, General & Administrative7.087.137.308.6711.9114.4414.443.4410.313.442.77
Operating Expenses29.1129.1136.0541.8393.2182.5482.5419.6543.8519.6518.85
Operating Income-21.44-21.44-35.95-23.72-83.92-72.36-72.36-19.17-43.15-19.17-17.33
Other Income/Expense
Interest Income2.302.303.804.280.380.080.080.630.630.920.71
Interest Expense0.46-0.46-0.851.11-0.690.36-0.360.20-0.200.140.09
Other Income/Expense3.533.532.516.464.410.890.890.750.972.742.07
Income
Income Before Tax-17.91-17.91-33.44-17.25-79.51-71.48-71.48-16.43-42.40-16.43-15.27
Income Tax Expense-0.300.300.021.69-0.461.70-1.700.00-0.00-0.55
Net Income-17.61-17.61-33.42-18.95-79.97-73.18-73.21-16.44-42.40-17.29-14.72
Net Income - Continuous Operations-17.61-17.61-33.42-18.95-79.97-73.18-73.18-16.44--17.29-14.72
Net Income - Discontinued Operations-----------
EBITDA-16.85-21.00-35.23-14.95-82.77-69.99-71.24-41.34-42.29-15.48-14.27
EBIT--21.44-35.95-23.72-83.92--72.36--43.15--
Depreciation & Amortization0.590.440.721.211.151.131.130.860.860.820.91
Earnings Per Share
Basic EPS---1.00-1.00-2.00-2.00-2.00-1.00-3.00--2.00
Diluted EPS---1.00-1.00-2.00-2.00-2.00-1.00-3.00--2.00
Basic Shares Outstanding37.7647.2045.0334.6443.3132.0240.0328.0712.7635.339.70
Diluted Shares Outstanding37.7647.2045.0335.0343.3132.0240.0328.0712.7635.339.70

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Adagene Financial Statements

What was Adagene's revenue in fiscal 2025?

Adagene reported revenue of $7.67M in fiscal 2025 (fiscal year ended Mar 31, 2026). That was up 7332.8% from $103.20K a year earlier.

Is Adagene profitable?

No. Adagene reported a net loss of $17.61M in fiscal 2025. In fiscal 2024 it lost $33.42M.

What is Adagene's operating margin?

Adagene's operating income was −$21.44M on revenue of $7.67M in fiscal 2025, an operating margin of -279.5%, compared with -34835.4% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition